Neoadjuvant Reirradiation for Radiotherapy Associated Angiosarcoma of the Breast

CONCLUSIONS: Our institutional analysis suggests excellent local control and survival outcomes for RAASB treated with surgery, neoadjuvant hyperfractionated reirradiation, and taxol based chemotherapy. However, major wound complications represent a major challenge with this approach. Future studies should consider how best to improve the therapeutic ratio while maintaining high rates of control and survival.PMID:38191096 | DOI:10.1016/j.ijrobp.2023.12.050
Source: Cancer Control - Category: Cancer & Oncology Authors: Source Type: research